FDA Succession Planning Targeted In House Legislation
Hamburg’s departure from commissioner post seems to be proceeding smoothly; proposals in 21st Century Cures bill would mandate a similar process always be followed.
You may also be interested in...
Senate legislation may be influenced by movement to push through Califf’s nomination for FDA commissioner.
FDA, PhRMA and BIO leadership could look considerably different under a modest proposal from National Health Council's Marc Boutin.
New discussion draft drops controversial exclusivity extensions and some other lesser-known ideas that may have benefited FDA and sponsors, but some placeholders still need to be filled.